Research map: Real-World Effect of Ruxolitinib Cream: Decreased Use of Additional Topical Therapies and Limited Escalation to Systemic Treatments

Back to the article

Papers in this map

  1. Comorbidity Measures for Use with Administrative Data · Anne Elixhauser · 1998 · 10045 citations · Cited by this paper
  2. Factors Associated with Favorable One-Year Outcomes After PreserFlo MicroShunt Implantation: Insights from Anterior Segment Optical Coherence Tomography · 2026 · Related
  3. Epidemiology of atopic dermatitis in adults: Results from an international survey · S. Barbarot · 2018 · 893 citations · Cited by this paper
  4. Uncontrolled Hypertension Prevalence, Characteristic Profiles, and Risk of Cardiorenal and Metabolic Outcomes: Insights from the EnligHTN Study · 2026 · Related
  5. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms · Alfonso Quintás‐Cardama · 2010 · 845 citations · Cited by this paper
  6. Diagnostic Delay in Multiple Sclerosis in China: A Nationwide Cross-Sectional Study · 2026 · Related
  7. Patient burden and quality of life in atopic dermatitis in US adults · Jonathan I. Silverberg · 2018 · 657 citations · Cited by this paper
  8. Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study · 2026 · Related
  9. Atopic dermatitis in the pediatric population · Jonathan I. Silverberg · 2021 · 464 citations · Cited by this paper
  10. Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods Study · 2026 · Related
  11. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population · Zelma C. Chiesa Fuxench · 2018 · 422 citations · Cited by this paper
  12. Long-Term Effects of Exercise During Pregnancy on the Metabolic Health of Mothers with Overweight/Obesity and Their Offspring: An 8- to 10-Year Follow-Up Study · 2026 · Related
  13. Glucocorticoid therapy‐induced skin atrophy · Stefanie Schoepe · 2006 · 340 citations · Cited by this paper
  14. Expert Consensus on the Clinical Application of Sulodexide in Vascular Diseases · 2026 · Related
  15. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies · Kim Alexander Papp · 2021 · 311 citations · Cited by this paper
  16. An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics · 2026 · Related
  17. Atopic dermatitis · Emma Guttman‐Yassky · 2025 · 308 citations · Cited by this paper
  18. Budget Impact of Eplerenone for Heart Failure with Reduced Ejection Fraction: National Perspective and Regional Implications in Italy · 2026 · Related
  19. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies · Dawn Marie R. Davis · 2023 · 257 citations · Cited by this paper
  20. Obstetric and Neonatal Factors Associated with Postpartum Depressive Symptoms: A Retrospective Multicenter EPDS-Based Study · 2026 · Related
  21. Guidelines of care for the management of atopic dermatitis in adults with topical therapies · Robert Sidbury · 2023 · 210 citations · Cited by this paper
  22. The socioeconomics of atopic dermatitis · Janice Chung · 2018 · 101 citations · Cited by this paper
  23. Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies · Kim Alexander Papp · 2022 · 101 citations · Cited by this paper
  24. European Guideline ( EuroGuiDerm ) on atopic eczema: Living update · Andreas Wollenberg · 2025 · 79 citations · Cited by this paper
  25. Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream · Paul A. Smith · 2021 · 30 citations · Cited by this paper
  26. Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year · Wilson Hu · 2024 · 26 citations · Cited by this paper
  27. Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study · Lawrence F. Eichenfield · 2025 · 22 citations · Cited by this paper
  28. Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database · Jinan Liu · 2025 · 8 citations · Cited by this paper
  29. Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives · Lawrence F. Eichenfield · 2024 · 7 citations · Cited by this paper
  30. Comparison of commercial insurance databases to census data for age, gender and geographic region in the united states · Thomas Wasser · 2013 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)